268 related articles for article (PubMed ID: 17043312)
1. Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease.
Bilodeau S; Vallette-Kasic S; Gauthier Y; Figarella-Branger D; Brue T; Berthelet F; Lacroix A; Batista D; Stratakis C; Hanson J; Meij B; Drouin J
Genes Dev; 2006 Oct; 20(20):2871-86. PubMed ID: 17043312
[TBL] [Abstract][Full Text] [Related]
2. Of old and new diseases: genetics of pituitary ACTH excess (Cushing) and deficiency.
Drouin J; Bilodeau S; Vallette S
Clin Genet; 2007 Sep; 72(3):175-82. PubMed ID: 17718852
[TBL] [Abstract][Full Text] [Related]
3. Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor.
Martens C; Bilodeau S; Maira M; Gauthier Y; Drouin J
Mol Endocrinol; 2005 Apr; 19(4):885-97. PubMed ID: 15591535
[TBL] [Abstract][Full Text] [Related]
4. Recruitment of the SWI/SNF protein Brg1 by a multiprotein complex effects transcriptional repression in murine erythroid progenitors.
Xu Z; Meng X; Cai Y; Koury MJ; Brandt SJ
Biochem J; 2006 Oct; 399(2):297-304. PubMed ID: 16800816
[TBL] [Abstract][Full Text] [Related]
5. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
[TBL] [Abstract][Full Text] [Related]
6. Nuclear receptors Nor1 and NGFI-B/Nur77 play similar, albeit distinct, roles in the hypothalamo-pituitary-adrenal axis.
Fernandez PM; Brunel F; Jimenez MA; Saez JM; Cereghini S; Zakin MM
Endocrinology; 2000 Jul; 141(7):2392-400. PubMed ID: 10875239
[TBL] [Abstract][Full Text] [Related]
7. BRG1, the ATPase subunit of SWI/SNF chromatin remodeling complex, interacts with HDAC2 to modulate telomerase expression in human cancer cells.
Wu S; Ge Y; Huang L; Liu H; Xue Y; Zhao Y
Cell Cycle; 2014; 13(18):2869-78. PubMed ID: 25486475
[TBL] [Abstract][Full Text] [Related]
8. mSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the Myc target gene cad.
Pal S; Yun R; Datta A; Lacomis L; Erdjument-Bromage H; Kumar J; Tempst P; Sif S
Mol Cell Biol; 2003 Nov; 23(21):7475-87. PubMed ID: 14559996
[TBL] [Abstract][Full Text] [Related]
9. IUGR increases chromatin-remodeling factor Brg1 expression and binding to GR exon 1.7 promoter in newborn male rat hippocampus.
Ke X; McKnight RA; Gracey Maniar LE; Sun Y; Callaway CW; Majnik A; Lane RH; Cohen SS
Am J Physiol Regul Integr Comp Physiol; 2015 Jul; 309(2):R119-27. PubMed ID: 25972460
[TBL] [Abstract][Full Text] [Related]
10. Repression of GR-mediated expression of the tryptophan oxygenase gene by the SWI/SNF complex during liver development.
Inayoshi Y; Kaneoka H; Machida Y; Terajima M; Dohda T; Miyake K; Iijima S
J Biochem; 2005 Oct; 138(4):457-65. PubMed ID: 16272140
[TBL] [Abstract][Full Text] [Related]
11. Transforming pathways unleashed by a HDAC2 mutation in human cancer.
Ropero S; Ballestar E; Alaminos M; Arango D; Schwartz S; Esteller M
Oncogene; 2008 Jun; 27(28):4008-12. PubMed ID: 18264134
[TBL] [Abstract][Full Text] [Related]
12. 60 YEARS OF POMC: Transcriptional and epigenetic regulation of POMC gene expression.
Drouin J
J Mol Endocrinol; 2016 May; 56(4):T99-T112. PubMed ID: 26792828
[TBL] [Abstract][Full Text] [Related]
13. Antagonism between Nur77 and glucocorticoid receptor for control of transcription.
Philips A; Maira M; Mullick A; Chamberland M; Lesage S; Hugo P; Drouin J
Mol Cell Biol; 1997 Oct; 17(10):5952-9. PubMed ID: 9315653
[TBL] [Abstract][Full Text] [Related]
14. Reprogramming of the SWI/SNF complex for co-activation or co-repression in prohibitin-mediated estrogen receptor regulation.
Zhang B; Chambers KJ; Faller DV; Wang S
Oncogene; 2007 Nov; 26(50):7153-7. PubMed ID: 17486062
[TBL] [Abstract][Full Text] [Related]
15. Reversal of glucocorticoids-dependent proopiomelanocortin gene inhibition by leukemia inhibitory factor.
Latchoumanin O; Mynard V; Devin-Leclerc J; Dugué MA; Bertagna X; Catelli MG
Endocrinology; 2007 Jan; 148(1):422-32. PubMed ID: 17038560
[TBL] [Abstract][Full Text] [Related]
16. Chromatin remodeling during glucocorticoid receptor regulated transactivation.
King HA; Trotter KW; Archer TK
Biochim Biophys Acta; 2012 Jul; 1819(7):716-26. PubMed ID: 22425674
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid hormone-induced receptor localization to the chromatin fibers formed on injected DNA in Xenopus oocytes.
Gelius B; Wrange O
Exp Cell Res; 2001 May; 265(2):319-28. PubMed ID: 11302698
[TBL] [Abstract][Full Text] [Related]
18. BRG1 chromatin remodeling activity is required for efficient chromatin binding by repressor element 1-silencing transcription factor (REST) and facilitates REST-mediated repression.
Ooi L; Belyaev ND; Miyake K; Wood IC; Buckley NJ
J Biol Chem; 2006 Dec; 281(51):38974-80. PubMed ID: 17023429
[TBL] [Abstract][Full Text] [Related]
19. The Cables1 Gene in Glucocorticoid Regulation of Pituitary Corticotrope Growth and Cushing Disease.
Roussel-Gervais A; Couture C; Langlais D; Takayasu S; Balsalobre A; Rueda BR; Zukerberg LR; Figarella-Branger D; Brue T; Drouin J
J Clin Endocrinol Metab; 2016 Feb; 101(2):513-22. PubMed ID: 26695862
[TBL] [Abstract][Full Text] [Related]
20. Cyclin E-Mediated Human Proopiomelanocortin Regulation as a Therapeutic Target for Cushing Disease.
Liu NA; Araki T; Cuevas-Ramos D; Hong J; Ben-Shlomo A; Tone Y; Tone M; Melmed S
J Clin Endocrinol Metab; 2015 Jul; 100(7):2557-64. PubMed ID: 25942479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
